BriaCell Therapeutics Corp. (BCTX) stock
BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.30−0.09 (-2.65%)
Close on Nov 16, 2026Market cap $28.82MP/E –Yield –
BriaCell Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BriaCell Therapeutics's enterprise value was $9.88M on Nov 11, 2026, against -$7.84M a year earlier. Over the last 5 years it ranged from -$25.21M to $93.83M, with a median of $16.80M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.88M | – |
| 2025 | Nov 28, 2025 | -$82.67K | -100.6% |
| 2024 | Dec 31, 2024 | $14.32M | -82.0% |
| 2023 | Dec 29, 2023 | $79.64M | +159.1% |
| 2022 | Dec 30, 2022 | $30.74M | -56.0% |
| 2021 | Dec 31, 2021 | $69.87M | +2250.9% |
| 2020 | Dec 31, 2020 | $2.97M | – |
See a number that looks wrong?